Paid Clinical Trials in Austin

Candace Kastanis

Written by Candace Kastanis

Chemistry B.S. | UC Davis | Clinical Lab Technician

Updated & Fact Checked 7/30/26

Finding Trials in Austin

Austin is a smaller research market than Texas’s other big cities, and it helps to know that going in. As of July 2026, 653 studies are actively recruiting here, according to ClinicalTrials.gov — well behind Houston and San Antonio. What Austin does have is a growing base of private research sites and a young medical school at UT Austin.

Austin has 558+ clinical trial opportunities, and each tends to involve more than one person. Trials can include only a handful of people or hundreds. How many will be available to you in Austin? Well, medical data indicates that .005% of the total U.S. population must be continuously engaged in research trials so the science can continue to advance. Multiply .005 by Austin’s population, which is 996,147, and you get 4,980.

At a minimum, expect 4,980 individual opportunities for paid clinical trials in Austin annually. However, at just 20 persons per a study, the 558 clinical trial opportunities available right now indicate a potential of 11,160 individual opportunities; or more than twice the national average. The point is that there are opportunities. We’ll cover where to find them and what to look for in greater detail here.

Quick Facts: Paid Clinical Trials in Austin

  • Actively recruiting studies (July 2026): 653 (ClinicalTrials.gov)
  • Typical compensation: $50–$100 per completed outpatient visit; residential Phase 1 studies pay more (see highest paid clinical trials)
  • Cost to participate: $0 — study care and visits are covered by the sponsor
  • Worth knowing: fewer trials run here than in Houston or San Antonio — many Austin residents also check San Antonio listings
  • Statewide options: paid clinical trials in Texas

Where Austin trials actually run

We sampled recruiting Austin studies on ClinicalTrials.gov in July 2026. The sites running the most trials:

Research siteTrials sampled
Dell Children’s Medical Center27
University of Texas at Austin26
FutureSearch Trials (neurology)9
Texas Cardiac Arrhythmia Research Foundation9

Austin’s research is spread across private specialty sites rather than one dominant academic center. Dell Children’s handles pediatrics, and dedicated trial companies run neurology, psychiatry, and dermatology studies. For a wider selection, San Antonio is about 80 miles south.

More and More Clinical Research Opportunities in Austin

Paid clinical trials nearby for healthy volunteers will generally be rooted in local demographic realities. You won’t find clinical trials testing congenital conditions of the Inuit people in south Miami. Likewise, you won’t find any sort of studies referencing Cuban hereditary conditions in Nome, Alaska. Demographic data in part determine what studies happen where.

Here is some fine demographic data that helps paint a picture. Caucasians, including Hispanics (who are roughly a third of the total Austin population), constitute 69.39% of residents. Blacks constitute 7.79% of the population, other races make up 7.82%, and Asians are at 7.71%. The average age of people living in the city is 33.7, with men at 33.4 and women at 34. Females make up 49.21% of the population, while men make up 50.79%. Accordingly, most studies will be aimed at Caucasian males in their early thirties; but the city is large enough you’ll find options for almost all ethnic groups and backgrounds.

Antiangiogenic Therapy for Children with Recurrent Medulloblastoma, Ependymoma and ATRT
Recruiting
Patients with relapsed medulloblastoma, ependymoma and ATRT have a very poor prognosis whether treated with conventional chemotherapy, high-dose chemotherapy with stem cell rescue, irradiation or combinations of these modalities. Antiangiogenetic therapy has emerged as new treatment option in solid malignancies. The frequent, metronomic schedule targets both proliferating tumor cells and endothelial cells, and minimizes toxicity. In this study the investigators will evaluate the use of biweekly... Read More
Gender:
ALL
Ages:
19 years and below
Trial Updated:
10/17/2024
Locations: Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois
Conditions: Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Recruiting
XLPAD is an observational study designed to evaluate the effectiveness and use of stent and non-stent based therapies among PAD patients. The study will create a registry that will include entry of procedural and clinical follow-up information into an online data collection software, REDCAP.Data available since Jan 1 2005 will be included in the registry, until 14,000 patients have been included. The primary objectives of this observational registry study are to: 1. Compare stent and non-stent... Read More
Gender:
ALL
Ages:
All
Trial Updated:
12/05/2023
Locations: Arkansas Heart Institute, Little Rock, Arkansas +1 locations
Conditions: Peripheral Arterial Disease
LOWER: Lomitapide Observational Worldwide Evaluation Registry
Recruiting
This global product exposure registry is a multicentre, long-term, prospective, observational cohort study (exposure registry), designed to evaluate the long term safety and effectiveness of lomitapide.
Gender:
ALL
Ages:
All
Trial Updated:
03/11/2024
Locations: Brookwood Baptist Medical Center, Birmingham, Alabama
Conditions: Homozygous Familial Hypercholesterolemia
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Recruiting
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-sma... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/29/2024
Locations: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
Conditions: ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, Stage IB Non-Small Cell Lung Carcinoma AJCC v7, Stage II Non-Small Cell Lung Cancer AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7, Stage IIB Non-Small Cell Lung Carcinoma AJCC v7, Stage IIIA Non-Small Cell Lung Cancer AJCC v7
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
Recruiting
Advanced airway interventions are common high risk, high stakes events for children in intensive care units (ICU) and emergency departments (ED), with risk for life and health threatening consequences.
Gender:
ALL
Ages:
All
Trial Updated:
01/21/2025
Locations: Children's of Alabama at Birmingham, Birmingham, Alabama
Conditions: Failed or Difficult Intubation, Sequela, Intubation; Difficult, Intubation Complication
Coflex PS3 Actual Conditions for Use Study
Recruiting
A 2 and 5 year evaluation of clinical outcomes in the treatment of degenerative spinal stenosis with concomitant low back pain by decompression with additional stabilization using the coflex® Interlaminar Technology for FDA Actual Conditions of Use Study.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/04/2024
Locations: Desert Institute for Spine Care (DISC), Phoenix, Arizona
Conditions: Spinal Stenosis Lumbar
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Recruiting
A prospective open label, multicenter study to evaluate the feasibility and acute toxicity of using molecularly guided therapy in combination with standard therapy followed by a Randomized Controlled Trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for Subjects with Newly Diagnosed High-Risk Neuroblastoma.
Gender:
ALL
Ages:
22 years and below
Trial Updated:
08/21/2024
Locations: University of Alabama, Children's of Alabama, Birmingham, Alabama
Conditions: Neuroblastoma
Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Patients With Schizophrenia
Recruiting
To evaluate the efficacy and safety of cariprazine at a target dose of 4.5 mg/d compared with placebo in prevention of relapse in patients with schizophrenia To evaluate the efficacy and safety of cariprazine at a target dose of 3.0 mg/d compared with placebo in prevention of relapse in patients with schizophrenia who were initially stabilized on a target dose of 4.5 mg/d
Gender:
All
Ages:
Between 18 years and 64 years
Trial Updated:
08/17/2020
Locations: Pillar Clinical Research, Bentonville, Arkansas
Conditions: Schizophrenia
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
Recruiting
This is a first-in-human study evaluating the anti-T cell immunoglobulin and mucin containing protein-3 (TIM-3) antibody TSR-022. The study will be conducted in 2 parts with Part 1 consisting of dose escalation and Part 2 dose expansion. Part 1 will determine the recommended Phase 2 dose (RP2D) of TSR-022 and Part 2 will evaluate the antitumor activity of TSR-022 in combination with TSR-042 or docetaxel and as monotherapy.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/14/2024
Locations: GSK Investigational Site, Goodyear, Arizona
Conditions: Neoplasms
A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation
Recruiting
The purpose of this study is to compare the efficacy, safety, and tolerability of ide-cel with lenalidomide (LEN) maintenance to that of LEN maintenance alone in adult participants with Newly Diagnosed Multiple Myeloma (NDMM) who have achieved a suboptimal response post autologous stem cell transplantation (ASCT).
Gender:
All
Ages:
18 years and above
Trial Updated:
05/01/2024
Locations: Banner MD Anderson Cancer Center, Gilbert, Arizona
Conditions: Multiple Myeloma

Trending Diversity in Austin Supports Paid Clinical Trial Opportunities

Paid clinical trials for healthy volunteers in Austin will center around diversity and diverse communities specifically, with institutions seeking participants who match a very narrow set of criteria. However, there will also be more broad studies. When there are 4,000 to 11,000 paid clinical trial opportunities at the individual level every year, and 500+ different studies, that’s a wide target.


CROs in Austin Are Seeking Trial Participants

To determine what’s available, you’ll want to do is look into local Clinical Research Organizations, or CROs, in and around Austin. Several to look into include:


Austin is a Center for Medical Breakthroughs

Being part of medical advances means you’re part of history, to a certain extent. Getting involved in healthy volunteer paid clinical trials helps others, and puts money in your pocket. You might be integral to medical advances that develop culture and society. Consider these links:


Austin Paid Clinical Trial FAQs

  • How much do paid clinical trials pay here?

    Most outpatient studies pay $50–$100 per completed visit, plus travel reimbursement. Residential Phase 1 studies pay considerably more. The exact amount appears in the consent form before you enroll.

  • Why are there fewer trials in Austin than in Houston or Dallas?

    Austin’s medical school at UT Austin opened in 2016, so the city lacks the decades-old academic research infrastructure that Houston, Dallas, and San Antonio have. Private research sites fill part of the gap, and the number of studies here is growing.

  • Where should I look if I cannot find an Austin study?

    San Antonio is roughly 80 miles away and runs about 990 studies, including residential Phase 1 research. Many sponsors reimburse travel, so a study there can still be practical. Dallas and Houston are options for specialized conditions.

Exploring Austin Research Trial Opportunities

You can help advance medical science, supplement income in a way that provides more disposable resources, and ultimately advance civilization overall. Paid clinical trials provide many opportunities, and Austin has lots of them. If you haven’t looked into this, it’s an opportunity to consider.